Skip to main content
. 2020 Feb;8(4):104. doi: 10.21037/atm.2019.12.113

Table 1. Characteristics of the study population by cognition status.

Characteristics All (n=297) Non-dementia (n=250) Dementia (n=47) P value
Demographic parameter
   Age (years) 56.8±6.9 56.4±6.6 58.7±8.3 0.087
   Female 105 (35.4) 81 (32.4) 24 (51.1) 0.019*
   Low education (≤12 years) 230 (77.4) 186 (74.4) 44 (93.6) 0.002*
   SBP (mmHg) 130.3±20.4 129.7±19.3 133.6±25.2 0.316
   BMI, kg/m2 24.6±3.3 24.5±3.2 25.2±3.8 0.169
   Waist circumference (cm) 91.6±9.8 91.1±9.5 93.7±10.9 0.095
   Smoker 90/286 (31.5) 80/241 (33.2) 10/45 (22.2) 0.165
   Moderate drinker 60/286 (21.0) 53/241 (22.0) 7/45 (15.6) 0.426
   TC (mmol/L) 4.26±1.10 4.26±1.12 4.25±1.02 0.815
   TG (mmol/L) 2.42±1.82 2.41±1.81 2.48±1.87 0.986
   HDL-C (mmol/L) 1.03±0.27 1.02±0.27 1.08±0.29 0.195
   LDL-C (mmol/L) 2.52±0.88 2.51±0.89 2.53±0.83 0.912
Diabetic parameter
   Course (years) 8.7±6.7 8.5±6.6 9.4±7.4 0.396
   Age at onset (years) 48.1±8.7 47.9±8.6 49.2±9.5 0.340
   FPG (mmol/L) 10.2±4.5 10.2±4.6 9.9±3.9 0.620
   FC-P (ng/mL) 1.17±0.8 1.16±0.80 1.20±0.79 0.768
   HOMA2-IR 3.5±2.6 3.4±2.6 3.7±2.7 0.548
   HOMA2-β 66.4±42.8 66.1±43.1 68.0±41.9 0.785
   SDBG (mmol/L) 3.2±1.3 3.2±1.3 3.2±1.4 0.970
   PPGE (mmol/L) 2.7±2.0 2.7±1.9 2.5±2.3 0.549
   LAGE (mmol/L) 9.7±4.1 9.8±4.1 9.7±4.2 0.903
   HbA1c (%) 8.9±2.1 8.9±2.1 9.1±1.9 0.550
   HbA1c >7.5% 212 (71.4) 176 (70.4) 36 (76.6) 0.482
   DR 146 (49.2) 118 (47.2) 28 (59.6) 0.152
   Diabetic nephropathy 77 (25.9) 62 (24.8) 15 (31.9) 0.364
   Macrovascular complications 203 (68.4) 166 (66.4) 37 (78.7) 0.123
   Diabetic peripheral neuropathy 155 (52.2) 128 (51.2) 27 (57.4) 0.525

Data are displayed in the form of n (%) or mean ± SD. *, There were significant differences between non-dementia group and dementia group. SBP, systolic blood pressure; BMI, body mass index; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; FPG, fasting plasma glucose; FC-P, fasting plasma C-peptide; HOMA2-IR, homeostasis model assessment 2 of insulin resistance index; HOMA2-β, homeostasis model assessment 2 of β-cell function; SMBG, self-monitoring of blood glucose; SDBG, standard deviation of blood glucose; PPGE, postprandial glucose excursion; LAGE, largest amplitude of glycemic excursions; HbA1c, hemoglobin A1c; DR, diabetic retinopathy.